Form 4: Labcorp SVP Sells Shares Under Pre-Arranged Plan

Peter J. Wilkinson, Labcorp's SVP and Chief Accounting Officer, sold 202 shares of common stock on July 29, 2025, under a Rule 10b5-1 trading plan.

Summary

• Peter J. Wilkinson, the Senior Vice President and Chief Accounting Officer of Labcorp Holdings Inc. (LH), reported transactions on July 29, 2025.
• The transactions involved the sale of common stock.
• Mr. Wilkinson sold 102 shares at a price of $261.0102 per share.
• Additionally, he sold 100 shares at a price of $261.035 per share.
• The total number of shares sold across these two transactions was 202.
• Following these reported transactions, Mr. Wilkinson beneficially owns 1,852.2194 shares of Labcorp common stock.
• The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to insider selling, but mitigated by the disclosure that the transaction was executed under a pre-arranged 10b5-1 plan, suggesting it was not based on new, adverse information.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, which indicates the transaction was pre-scheduled and not based on immediate, non-public information, potentially mitigating negative perceptions of insider selling.

Negatives

• Insider selling, even when pre-planned, can sometimes be interpreted by the market as a signal that an executive believes the stock may be fully valued or that future growth prospects are limited.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it is solely a report of insider transactions.

Industry Context

This filing is a routine insider transaction report specific to Labcorp Holdings Inc. and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders may view the insider sale as a neutral to slightly negative signal, although the 10b5-1 plan helps to alleviate concerns that the sale is based on negative undisclosed information.

Key Dates

Recommendation

The sale of shares by a senior executive, while typically a negative signal, was conducted under a Rule 10b5-1 plan. This indicates the transaction was pre-scheduled and not necessarily reflective of a change in the executive's outlook on the company's immediate prospects. Without additional context or other significant company news, this single insider sale does not warrant a strong buy or sell recommendation, suggesting a 'hold' position for investors.

Keywords

Labcorp, LH, insider trading, Form 4, stock sale, Peter J. Wilkinson, beneficial ownership, 10b5-1 plan